Skip to content

Body mass index is sufficient to predict diabetes or metabolic syndrome, Italian study finds

Dr Jovana Milić presenting at EACS 2023. Photo by Roger Pebody.

Greater weight gain in first year of HIV treatment raises risks of diabetes, metabolic syndrome and precursors of heart disease

Shutterstock Studios HIV in View gallery

Top 5 stories on co-infections and co-morbidities in people with HIV from IAS 2023

sqofield/Shutterstock.com

Top 5 HIV treatment stories from IAS 2023

Rhiannon Neale Photography

Integrase inhibitors raise the risk of diabetes regardless of weight gain

Dhanushi Rupasinghe at IAS 2023.

Switches away from integrase inhibitors do not reverse weight gain, studies find

Dr William Short presenting the DEFINE study findings at IAS 2023.

Diagnosis and treatment for high blood pressure need to be funded as part of HIV treatment programmes

Professor Francois Venter at IAS 2023. Photo by Roger Pebody.

No link between weight gain on integrase inhibitors and diabetes

Blue_Deep/Shutterstock.com

Top 5 stories on injectable HIV treatment and PrEP from CROI 2023

Professor Mark Marzinke presenting at CROI 2023. Photo by Roger Pebody.